A spinal cord injury patient in the US has become the first ever to be injected with human embryonic stem cells in a federally-approved trial.
The patient is enrolled at the spinal cord and brain injury Shepherd Center in Atlanta, which is one of the units participating in biopharmaceutical firm Geron's trials.
To be included in the programme, the patient must be newly injured and receive treatment within 14 days.
Geron boss Thomas Okarma described the clinical trial as a "milestone" in human embryonic stem cell (hESC) research.
"When we started working with hESCs in 1999, many predicted that it would be a number of decades before a cell therapy would be approved for human clinical trials," he added.
He also hailed the research and development that went into producing the treatment, known as GRNOPC1.
The news comes after researchers at the Karolinska Institutet have identified a stem cell that becomes active when a spinal cord is injured.
News from Serious Law, specialist spinal injury compensation solicitors
Posted by Paul Breen